European Heart Journal Advance Access originally published online on May 4, 2007
European Heart Journal 2007 28(19):2312; doi:10.1093/eurheartj/ehm100
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
A stone heart: fatal cardiac microcalcification
1 Division of Nuclear Medicine, Department of Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Room 1258, Los Angeles, CA 90048, USA
2 Department of Anatomic and Clinical Pathology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
* Corresponding author. Tel: +1 310 423 0755; fax: +1 310 423 0811. E-mail address: louise.thomson@cshs.org
| The first 10% of the full text of this article appears below. |
Marked cardiac uptake of 99mTc-methyl-diphosphonate was noted on a bone scan performed in a patient with end-stage renal failure, on long-term dialysis. Amyloidosis was considered a possible explanation for clinical features that included severe left ventricular hypertrophy,